Ebei Cloud Completes Tens of Millions of RMB A+ Financing Round with Needle Capital as Exclusive Financial Advisor

VCBeat has learned that Yibei Cloud Services (Hangzhou) Technology Co., Ltd. (“Yibei Cloud Services” or the “Company”) recently announced the completion of its tens-of-millions-yuan A+ round financing. The round was led by LCIG, with participation from Zheyin Fucheng and Tanxin New Medical Fund. Tanxin Capital served as the exclusive financial advisor.

Founded in 2019, Yibei Cloud Services is dedicated to providing intelligent and digital procurement and supply chain operation solutions for enterprises across the entire healthcare industry. Adhering to its core philosophy of “leveraging digital technology to deliver competitive products and services, and continuously creating maximum value for customers,” the company has successfully implemented its solutions in over 100 medical institutions and thousands of healthcare enterprises. Following this round of financing, the company will further increase its investment in R&D for intelligence and big data applications, as well as upgrade its SPD (Supply, Processing, and Distribution) supply chain service capabilities. These efforts aim to enhance customer product experience, build a comprehensive product system that integrates the entire healthcare industry chain, and accelerate market expansion.

With the development of digital and intelligent medical supply chains, YiBei Cloud Service will expand its services in three major directions: service breadth, service depth, and foundational capabilities. In terms of breadth, it will build a one-stop SaaS solution that interconnects the upstream and downstream of the healthcare industry, achieving the integration of four flows: supply chain logistics, information flow, capital flow, and commercial flow. In terms of depth, it will effectively integrate intelligent systems, operational management, and management tools to enhance service quality and achieve comprehensive coverage of demands. Regarding foundational capabilities, it will continuously refine seven core underlying competencies—information technology construction, engineering, operational services, commercial implementation, product and model innovation, deep understanding of the medical industry, and resource integration—to ensure the quality of solution implementation. Thereby, it aims to provide customers with efficient, intelligent, integrated, professional, and standardized medical supply chain services, fostering a platform ecosystem that covers the entire healthcare industry.

In 2016, Lenovo Capital and Incubator Group (LCIG) was officially established. As Lenovo’s global technology industry fund, it aims to leverage Lenovo’s global resources to shape the future of technology through investment and incubation. LCIG focuses on investments in the technology sector, with key areas including IoT, edge computing, cloud computing, big data, artificial intelligence, AI-enabled industries, and consumption upgrades. To date, LCIG has invested in nearly 200 outstanding companies, including more than 10 that have gone public, such as CATL, Meituan, NIO, Cambricon, SUPCON, and Zhuhai CosMX, as well as over 40 unicorns in niche sectors, such as Megvii, 4Paradigm, SmartSens, BYD Semiconductor, SemiDrive, and Yunji Technology.

LCIG leverages its innovative Corporate VC 2.0 model to fully capitalize on Lenovo’s global brand, distribution channels, and supply chain advantages. By bridging business collaboration between portfolio companies and Lenovo Group, LCIG has effectively facilitated the industrial application of cutting-edge technologies, fostering an ecosystem of complementary strengths, close synergy, and mutual success.

Probe Capital was founded in 2017 as a boutique investment bank specializing in healthcare and life sciences. Its business lines encompass financial advisory, direct investment, industry consulting, and innovation incubation. The founding team hails from leading private equity firms, financial advisory institutions, management consulting companies, and vertical medical media outlets. Since its inception, Probe Capital has consistently completed double-digit private financing and M&A transactions annually, with cumulative transaction value exceeding RMB 10 billion. In terms of value-added services for portfolio companies, the Probe Capital team brings extensive industry expertise. In 2020, Probe New Healthcare Fund was established and has since invested in more than ten leading companies in the sector.